Rhubarb Root (Rheum palmatum)

Rheum palmatum L. and Rheum officinale Baill.
Evidence Level
Limited
6 Clinical Trials
6 Documented Benefits
2/5 Evidence Score

Rhubarb root, also called Chinese rhubarb or da huang, is the dried underground part of Rheum palmatum, Rheum officinale or their hybrids. It is a stimulant laxative: its anthraquinone glycosides and sennosides reach the colon intact, where bacteria turn them into active anthrones that speed transit and keep water in the stool. Its tannins are astringent, and it is considered milder than other anthraquinone laxatives. EU regulators accept it as an herbal medicine for up to 1 week of use in occasional constipation, though their review found no controlled studies of the root alone; one small placebo-controlled trial, sponsored by the extract maker, has been published since. It is not rhapontic rhubarb (Rheum rhaponticum), a menopause extract, nor the culinary stalk. A July 2026 EU draft regulation would ban rhubarb root preparations in foods if adopted.

Studied Dose Trial: rhubarb root extract tablets giving 12.5 or 25 mg hydroxyanthracene derivatives (as rhein) daily at bedtime for 30 days. EU monograph: 20 to 30 mg (as rhein) once daily at night, or a tea with no more than 30 mg in 150 ml boiling water, for no more than 1 week.
Active Compound Hydroxyanthracene derivatives (3 to 12% of the root): mainly mono- and diglycosides of rhein, emodin, aloe-emodin, chrysophanol and physcion, plus 10 to 25% dianthrone glycosides (sennosides A to F). Pharmacopoeia-grade root has at least 2.2% expressed as rhein and must be free of rhaponticin. Also about 5% gallotannins.

Benefits

Bowel movement frequency and stool consistency over 30 days

In a double-blind trial in 42 middle-aged adults (95% women) with few bowel movements per week, a rhubarb root extract giving 25 mg anthraquinone derivatives a day improved stool frequency and consistency versus placebo, starting in the first week. The 12.5 mg dose improved consistency after 4 weeks. The trial was small and sponsored by the extract maker.

Herbal laxative accepted in the EU for short-term occasional use

EU herbal medicine regulators accept rhubarb root, standardized to its anthraquinone content, for short-term relief of occasional constipation in adults and adolescents. Their review found no controlled studies of the root alone and based the decision on long medicinal use, expert opinion and trials of related laxatives such as senna and aloe.

Bedtime dose with a bowel movement 8 to 12 hours later

Rhubarb root glycosides must travel to the colon and be converted by bacteria before they act, so the EU monograph advises a single dose at night and states that a bowel movement follows after 8 to 12 hours. It adds that 2 or 3 doses in a week are usually enough and that the right dose is the smallest that gives a soft, formed stool.

Butyrate-producing gut bacteria and short-chain fatty acids

In the same 30-day placebo-controlled trial, stool acetate, propionate and butyrate rose on rhubarb extract and not on placebo, but only butyrate on the 12.5 mg dose differed significantly from placebo. Lachnospiraceae bacteria such as Roseburia increased mainly on that lower dose, and higher short-chain fatty acid levels went with softer stools. These were secondary outcomes in a small trial.

Gut barrier permeability markers in one small hospital trial

In 40 hospitalized patients with sepsis, crude rhubarb powder (3 g three times daily by mouth) added to standard care was followed by a lower urine lactulose to mannitol ratio and lower blood D-lactate on day 6 than in the control group, both markers of gut permeability. The trial was small, the abstract does not describe blinding, and it was a drug-use setting.

Body weight and gut bacteria in mice on a high-fat, high-sugar diet (animal study)

In mice fed a high-fat, high-sucrose diet for 8 weeks, adding 0.3% Rheum palmatum root extract to the food prevented the weight gain, fat build-up and high blood sugar seen in untreated mice, along with a rise in the gut bacterium Akkermansia muciniphila. This was an animal study, and these effects have not been tested in people.

Mechanism of action

1

Activation by colon bacteria

The glycosides in rhubarb root are not split by human digestive enzymes, so little is absorbed in the upper gut. Colon bacteria convert them into active anthrones; in mouse studies rhein anthrone, the active form of the sennosides found in rhubarb and senna, was a stronger purgative than the free anthraquinones. Rhein, emodin and traces of chrysophanol then appear in human urine.

2

Faster colonic transit and more water in the stool

The EU monograph describes two actions of the active anthrones: they stimulate motility of the large intestine, speeding transit, and they reduce absorption of water, sodium and chloride while increasing secretion of water and electrolytes into the colon. In mice, rhein anthrone and aloe-emodin anthrone acted together on both transit and water secretion.

3

Tannins with an astringent effect

Rhubarb root contains about 5% gallotannins. The EU assessment notes that these tannins may partly counteract the laxative effect, so rhubarb is considered milder than other anthranoid laxatives, and older reference texts describe small doses of 0.1 to 0.3 g acting mainly as an astringent rather than a laxative.

Clinical trials

1
Rhubarb Root Extract at Two Doses vs Placebo in Adults With Infrequent Bowel Movements: 30-Day RCT
PubMed

Randomized, double-blind, placebo-controlled trial at a private clinical investigation center in Dijon, France (2017 to 2018), of Rheum palmatum root extract tablets (Gutisrheum, Laboratoires Ortis) giving 12.5 mg or 25 mg hydroxyanthracene derivatives (as rhein) daily at bedtime versus maltodextrin placebo for 30 days. Sponsored by Laboratoires Ortis; registered as NCT05541991 in 2022, after completion. The registry names change in weekly bowel movements as the primary outcome and lists 45 enrolled and several gut hormone, permeability and inflammation outcomes that the paper does not report. (Neyrinck et al. 2022, Int J Mol Sci)

42 middle-aged volunteers (95% women, average age 58) with about 2.3 bowel movements per week at baseline; 13 per group were analyzed.

Stool frequency and consistency improved more on the 25 mg dose than on placebo from the first week; the 12.5 mg dose improved consistency after 4 weeks. Improved transit speed was reported by 92% on 25 mg, 62% on 12.5 mg and 23% on placebo. Stool short-chain fatty acids rose on rhubarb, but only butyrate on 12.5 mg differed significantly from placebo. Days with abdominal discomfort rose on rhubarb (by 0.2 and 2.2 days on average) and fell on placebo, and the number of people with diarrhea or loose stools rose significantly on 25 mg.

2
Crude Rhubarb Powder Added to Standard Care in Hospitalized Patients With Sepsis: Randomized Trial
PubMed

Randomized controlled trial by authors from Zhejiang University, China; both groups had the same treatment, and one group also took crude rhubarb powder 3 g three times daily by mouth. The abstract does not state blinding, the rhubarb species or funding. (Fang et al. 2007, Am J Chin Med)

40 patients with sepsis (18 given rhubarb, 22 controls).

On day 1 the groups did not differ. On day 6 the urine lactulose to mannitol ratio was 0.062 with rhubarb versus 0.167 in controls, and blood procalcitonin and D-lactate were also lower with rhubarb (P < 0.05 for each). No clinical outcomes such as survival were reported in the abstract.

3
Rheum officinale in People With Long-Term Kidney Problems: Cochrane Systematic Review
PubMed

Cochrane systematic review of randomized and quasi-randomized trials of Rheum officinale (da huang), with searches of English and Chinese databases to 2011 and no restriction on dose or route of use. (Wang et al. 2012, Cochrane Database Syst Rev)

9 trials with 682 participants with chronic kidney disease; 7 compared rhubarb with no treatment and 2 with captopril.

Against no treatment, rhubarb lowered serum creatinine and blood urea nitrogen, but no trial reported blinding or how groups were allocated. Against captopril there was no significant difference for any outcome, and no trial reported mortality. Only minor adverse events were reported. The reviewers judged the evidence scant and low quality and found no basis for any recommendation.

4
Rhein Levels After Oral vs Retention-Enema Rhubarb Extract in Healthy Men: Crossover Pharmacokinetic Study
PubMed

Prospective crossover study in which each volunteer received a single 50 mg/kg dose of an aqueous Rheum officinale extract (about 54 mg hydroxyanthracene derivatives for a 60 kg person, per the EU assessment) once by mouth and once as a retention enema, with plasma rhein measured by HPLC. The EU assessment of this study notes that 2 volunteers had mild to moderate diarrhea that resolved on its own. (Zhu et al. 2005, Am J Chin Med)

8 healthy male volunteers.

Peak rhein level and total exposure were significantly higher after oral dosing than after the enema, while time to peak, half-life and clearance did not differ. There was no placebo group and no laxative outcome.

5
Rheum palmatum Extract in Mice on a High-Fat, High-Sugar Diet: Animal Study
PubMed

Animal study in which male mice ate a control diet, a high-fat, high-sucrose diet, or the same diet with 0.3% rhubarb root extract (Ortis; 5.07% anthracene derivatives as rhein) for 8 weeks. (Régnier et al. 2020, Nutrients)

C57BL/6J male mice; no people were dosed.

The extract prevented diet-induced weight gain, visceral fat, high blood sugar, fat tissue inflammation and liver fat build-up without changing food intake, and these effects went with a large rise in Akkermansia muciniphila. Results in mice do not show the same effect in people.

6
Rhubarb Extract Before an Alcohol Binge in Mice: Animal Study
PubMed

Animal study in which mice ate a control diet with or without 0.3% rhubarb extract for 17 days and were examined 6 hours after an alcohol challenge; the extract also increased crypt depth, tissue weight and antimicrobial peptide expression in the gut. The same research group later identified its extract as Rheum palmatum root. (Neyrinck et al. 2017, Mol Nutr Food Res)

Mice; no people were dosed.

The extract shifted the bacterial mix toward Akkermansia muciniphila and Parabacteroides goldsteinii and lowered markers of liver inflammation and oxidative stress after alcohol, without significantly changing liver fat. This is animal work only.

Side effects and drug interactions

Common Potential side effects

Abdominal pain, cramping and liquid stools can occur, especially with an irritable bowel or too large a dose; the EU monograph says to lower the dose. In a 30-day trial, diarrhea or loose stools became significantly more common on the 25 mg dose.
Long-term use may cause loss of water and electrolytes, especially potassium, and may lead to protein or blood in the urine. Overdose causes griping pain and severe diarrhea; the EU monograph advises monitoring potassium, especially in the elderly.
Chronic use can darken the lining of the colon (pseudomelanosis coli), which usually fades after stopping. Harmless yellow or red-brown discoloration of urine and allergic reactions such as itching, hives or rash can occur.
Chronic overdose of anthranoid laxatives may cause toxic hepatitis. The EU review found no reports for rhubarb root alone; in a Hong Kong study of herbal liver injury, Rheum palmatum was one suspected component among more than ten herbs taken together.
EU food safety experts concluded in 2018 that hydroxyanthracene derivatives should be treated as genotoxic and carcinogenic unless shown otherwise, and in 2024 they could not establish the safety of rhubarb root preparations. In rats, high doses of rhubarb anthraquinones for 13 weeks harmed the kidneys.
Culinary rhubarb is high in oxalate, and a case of kidney failure from oxalate crystals has been reported after heavy eating of rhubarb in a person with diabetic kidney changes. The EU monograph does not address oxalate in the root, and it warns people with kidney disorders about electrolyte imbalance.
Not for use in pregnancy, while breastfeeding or in children under 12, according to the EU monograph, and not with bowel obstruction, appendicitis, inflammatory bowel disease, unexplained abdominal pain or severe dehydration. The US LactMed database notes that recent reviewers advise against use while breastfeeding.
Use beyond a brief period may impair normal bowel function and lead to reliance on laxatives; the EU monograph advises no more than 1 week of use and says rhubarb root should be used only when a change of diet or a bulk-forming fiber has not worked.

Important Drug interactions

Digoxin and other cardiac glycosides: low potassium from long-term or excessive use can strengthen their effect; consult a doctor before combining.
Antiarrhythmic drugs such as quinidine and medicines that prolong the QT interval: low potassium can interfere with them; consult a doctor before combining.
Diuretics (especially thiazide and loop diuretics), corticosteroids and licorice root can add to potassium loss when taken with rhubarb root.

Frequently asked questions about Rhubarb Root (Rheum palmatum)

Is rhubarb root the same as the rhubarb stalks sold for pies?

No. Rhubarb root supplements use the dried underground parts of Rheum palmatum or Rheum officinale, which contain laxative anthraquinones. The stalks of garden rhubarb are a food that FDA generally recognizes as safe, but they are high in oxalate, and very heavy eating of rhubarb has been linked to oxalate kidney injury in a reported case.

How is Chinese rhubarb root different from rhapontic rhubarb (ERr 731)?

They are different species used for different purposes. Rhapontic rhubarb (Rheum rhaponticum) root is the source of the ERr 731 extract studied for menopausal complaints, and its key compounds are stilbenes such as rhaponticin. Chinese rhubarb root is an anthraquinone laxative, and the European Pharmacopoeia requires it to be shown free of rhaponticin, which helps detect substitution.

Why is rhubarb root considered a milder laxative than other anthraquinone laxatives?

Besides its laxative anthraquinones, rhubarb root contains about 5% tannins, which are astringent. EU assessors note that these tannins may partly counteract the laxative effect, and older reference texts describe small doses of 0.1 to 0.3 g acting mainly as an astringent. Laxative doses are standardized to the anthraquinone content, not to the weight of root.

Is rhubarb root still allowed in food supplements in the EU?

Since 2021, EU food law has kept rhubarb root preparations containing hydroxyanthracene derivatives under scrutiny, and emodin and aloe-emodin, both present in the root, are on the prohibited list for foods. EFSA could not establish their safety in 2024, and a draft regulation sent to the Council in July 2026 would ban them in foods if adopted. Herbal medicine rules are separate.

What is Rhubarb Root?

Rhubarb root, also called Chinese rhubarb or da huang, is the dried underground part of Rheum palmatum, Rheum officinale or their hybrids. It is a stimulant laxative: its anthraquinone glycosides and sennosides reach the colon intact, where bacteria turn them into active anthrones that speed transit and keep water in t…

What is Rhubarb Root used for?

Rhubarb Root is researched primarily for Gut Health. In a double-blind trial in 42 middle-aged adults (95% women) with few bowel movements per week, a rhubarb root extract giving 25 mg anthraquinone derivatives a day improved stool frequency and consistency versus placebo, starting in the fir…

What is the recommended dosage of Rhubarb Root?

The clinically studied dose is Trial: rhubarb root extract tablets giving 12.5 or 25 mg hydroxyanthracene derivatives (as rhein) daily at bedtime for 30 days. EU monograph: 20 to 30 mg (as rhein) once daily at night, or a tea with no more than 30 mg in 150 ml boiling water, for no more than… Always follow the product label and check with a healthcare provider for personal advice.

Is Rhubarb Root safe, and does it have side effects?

Side effects and cautions reported for Rhubarb Root include: Abdominal pain, cramping and liquid stools can occur, especially with an irritable bowel or too large a dose; the EU monograph says to lower the dose. In a 30-day trial, diarrhea or loose stools became significantly more common on the 25 mg dose. It may also interact with some medications. Rhubarb Root is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Rhubarb Root interact with any medications?

Possible interactions include: Digoxin and other cardiac glycosides: low potassium from long-term or excessive use can strengthen their effect; consult a doctor before combining. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Rhubarb Root?

NutraSmarts rates the evidence for Rhubarb Root as Limited (2 out of 5). It is backed by 6 study summaries and 16 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(16 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. European Medicines Agency, Committee on Herbal Medicinal Products (HMPC). European Union herbal monograph on Rheum palmatum L. and Rheum officinale Baillon, radix. Final, Revision 1. EMA/HMPC/113700/2019. European Medicines Agency. 2020;Adopted by the HMPC 6 May 2020..SourceUsed to support: Not PubMed-indexed; official EU monograph, read in full. Well-established use for short-term use in occasional constipation; preparations equal to 20 to 30 mg hydroxyanthracene derivatives (as rhein) once daily at night, or a tea with no more than 30 mg in 150 ml boiling water; no more than 1 week. Describes bacterial activation, motility and secretory effects, an 8 to 12 hour delay, pseudomelanosis coli, electrolyte loss, albuminuria and hematuria with long-term use, urine discoloration, toxic hepatitis with chronic overdose, interactions with cardiac glycosides, antiarrhythmics, QT-prolonging drugs, diuretics, corticosteroids and licorice root, and kidney toxicity in rats given high doses of rhubarb anthraquinones for 13 weeks. Contraindicated in pregnancy, lactation and children under 12.
  2. European Medicines Agency, Committee on Herbal Medicinal Products (HMPC). Assessment report on Rheum palmatum L. and Rheum officinale Baillon, radix. Final, Revision 1. EMA/HMPC/113701/2019. European Medicines Agency. 2020;Dated 6 May 2020. First assessment rapporteur W Knöss; revision rapporteur J Wiesner..SourceUsed to support: Not PubMed-indexed; official EU assessment report, read. Root contains 3 to 12% hydroxyanthracene derivatives (60 to 80% mono- and diglycosides of aloe-emodin, chrysophanol, emodin, physcion and rhein; 10 to 25% sennosides), about 5% gallotannins, and per the European Pharmacopoeia no rhaponticin. States that clinical investigations test rhubarb root only in combinations, that there are no controlled clinical studies or clinical safety studies, and that tannins may counteract the laxative effect, making rhubarb milder; older texts describe small doses (0.1 to 0.3 g) as astringent. Summarizes the oral versus enema pharmacokinetic study, including 2 volunteers with diarrhea, and a liver injury study in which Rheum palmatum was taken with more than ten other herbs.
  3. European Commission. Commission Regulation (EU) 2021/468 of 18 March 2021 amending Annex III to Regulation (EC) No 1925/2006 of the European Parliament and of the Council as regards botanical species containing hydroxyanthracene derivatives. Official Journal of the European Union. 2021;OJ L 96, 19.3.2021, p. 6..SourceUsed to support: Not PubMed-indexed; EU regulation, read. Added emodin, aloe-emodin, danthron and preparations in which they are present, and Aloe leaf preparations containing hydroxyanthracene derivatives, to Part A (prohibited) of Annex III. Placed preparations from the root or rhizome of Rheum palmatum L., Rheum officinale Baillon and their hybrids containing hydroxyanthracene derivatives, with senna and frangula preparations, under Union scrutiny in Part C, based on the 2018 EFSA opinion.
  4. European Commission; Council of the European Union. Draft Commission Regulation (EU) amending Annex III to Regulation (EC) No 1925/2006 as regards certain botanical species containing hydroxyanthracene derivatives (SANTE/1196/2024 Rev.3, Council document 11964/26). Council of the European Union. 2026;Cover note dated 15 July 2026; Commission document D099926/3..SourceUsed to support: Not PubMed-indexed; draft EU regulation sent to the Council, read. Would move preparations from the root or rhizome of Rheum palmatum L., Rheum officinale Baillon and their hybrids containing hydroxyanthracene derivatives, together with the senna and frangula entries, from Part C to Part A (prohibited) of Annex III, because EFSA could not establish their safety in 2024. Foods already lawfully on the market could stay for 12 months after entry into force (Article 2). A draft, not yet in force when read.
  5. EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS), Younes M, Aggett P, Aguilar F, Crebelli R, Filipič M, Frutos MJ, Galtier P, Gott D, Gundert-Remy U, Kuhnle GG, Lambré C, Leblanc JC, Lillegaard IT, Moldeus P, Mortensen A, Oskarsson A, Stankovic I, Waalkens-Berendsen I, Woutersen RA, Andrade RJ, Fortes C, Mosesso P, Restani P, Pizzo F, Smeraldi C, Papaioannou A, Wright M. Safety of hydroxyanthracene derivatives for use in food. EFSA J. 2018;16(1):e05090. doi: 10.2903/j.efsa.2018.5090.PubMedUsed to support: EFSA opinion on hydroxyanthracene derivatives in food. Emodin, aloe-emodin and danthron were genotoxic in vitro, aloe-emodin was genotoxic in vivo, and whole-leaf aloe extract and danthron were carcinogenic. The Panel concluded that hydroxyanthracene derivatives should be considered genotoxic and carcinogenic unless specific data show otherwise, such as for rhein, and could not set a daily intake free of health concern.
  6. EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Turck D, Bohn T, Castenmiller J, De Henauw S, Hirsch-Ernst KI, Knutsen HK, Mangelsdorf I, McArdle HJ, Naska A, Pentieva K, Siani A, Thies F, Tsabouri S, Vinceti M, Rossi A, Titz A, Fiolet T, Maciuk A. Scientific Opinion on additional scientific data related to the safety of preparations of Rheum palmatum L., Rheum officinale Baill. and their hybrids, Rhamnus purshiana DC., Rhamnus frangula L. and Cassia senna L., submitted pursuant to Article 8(4) of Regulation (EC) No 1925/2006. EFSA J. 2024;22(5):e8766. doi: 10.2903/j.efsa.2024.8766.PubMedUsed to support: EFSA review of genotoxicity data submitted during the Union scrutiny of rhubarb root, cascara, frangula and senna preparations. All submitted studies were negative, but the preparations were poorly characterized and contained a compound known to be genotoxic in vivo, so the Panel concluded that the safety of rhubarb root preparations containing hydroxyanthracene derivatives cannot be established.
  7. Neyrinck AM, Rodriguez J, Taminiau B, Herpin F, Cani PD, Daube G, Bindels LB, Delzenne NM. Constipation Mitigation by Rhubarb Extract in Middle-Aged Adults Is Linked to Gut Microbiome Modulation: A Double-Blind Randomized Placebo-Controlled Trial. Int J Mol Sci. 2022;23(23):14685. doi: 10.3390/ijms232314685.PubMedUsed to support: Double-blind randomized trial (full text read) of a Rheum palmatum root extract giving 12.5 or 25 mg hydroxyanthracene derivatives (as rhein) daily versus placebo for 30 days in 42 middle-aged volunteers, 95% women. The higher dose improved stool frequency and consistency versus placebo, the lower dose improved consistency after 4 weeks, short-chain fatty acids rose on rhubarb, and loose stools increased on the higher dose. Sponsored by Laboratoires Ortis, with Walloon regional research funding; registered after completion (NCT05541991).
  8. Fang XL, Fang Q, Luo JJ, Zheng X. Effects of crude rhubarb on intestinal permeability in septic patients. Am J Chin Med. 2007;35(6):929-36. doi: 10.1142/S0192415X07005399.PubMedUsed to support: Randomized trial in 40 patients with sepsis (18 rhubarb, 22 control) in which one group also took crude rhubarb powder 3 g three times daily by mouth. On day 6 the urine lactulose to mannitol ratio and plasma procalcitonin and D-lactate were significantly lower in the rhubarb group. Small, with no blinding described in the abstract.
  9. Wang H, Song H, Yue J, Li J, Hou YB, Deng JL. Rheum officinale (a traditional Chinese medicine) for chronic kidney disease. Cochrane Database Syst Rev. 2012;2012(7):CD008000. doi: 10.1002/14651858.CD008000.pub2.PubMedUsed to support: Cochrane review of 9 trials (682 participants). Versus no treatment, Rheum officinale lowered serum creatinine and blood urea nitrogen; versus captopril, no significant difference. No trial reported blinding or allocation methods, only minor adverse events were reported, and the reviewers judged the evidence scant and low quality, with no basis for recommending use.
  10. Zhu W, Wang XM, Zhang L, Li XY, Wang BX. Pharmacokinetic of rhein in healthy male volunteers following oral and retention enema administration of rhubarb extract: a single dose study. Am J Chin Med. 2005;33(6):839-50. doi: 10.1142/S0192415X05003508.PubMedUsed to support: Crossover study in 8 healthy men given a single 50 mg/kg dose of rhubarb extract by mouth and by retention enema. Peak plasma rhein, area under the curve and AUMC were significantly higher after oral dosing; time to peak, half-life, mean residence time and clearance did not differ.
  11. Régnier M, Rastelli M, Morissette A, Suriano F, Le Roy T, Pilon G, Delzenne NM, Marette A, Van Hul M, Cani PD. Rhubarb Supplementation Prevents Diet-Induced Obesity and Diabetes in Association with Increased Akkermansia muciniphila in Mice. Nutrients. 2020;12(10):2932. doi: 10.3390/nu12102932.PubMedUsed to support: Mouse study (full text read) of a Rheum palmatum root extract from Ortis at 0.3% of a high-fat, high-sucrose diet for 8 weeks. The extract prevented diet-induced obesity, high blood sugar, visceral fat, adipose inflammation and liver triglyceride build-up without changing food intake, alongside a bloom of Akkermansia muciniphila. Animal study only.
  12. Neyrinck AM, Etxeberria U, Taminiau B, Daube G, Van Hul M, Everard A, Cani PD, Bindels LB, Delzenne NM. Rhubarb extract prevents hepatic inflammation induced by acute alcohol intake, an effect related to the modulation of the gut microbiota. Mol Nutr Food Res. 2017;61(1). doi: 10.1002/mnfr.201500899.PubMedUsed to support: Mouse study: 0.3% rhubarb extract in the diet for 17 days changed the gut microbiota, reduced liver inflammation and oxidative stress markers after an alcohol challenge without significantly affecting steatosis, and increased gut crypt depth and antimicrobial peptide expression. Animal study only.
  13. National Institute of Child Health and Human Development. Rhubarb. Drugs and Lactation Database (LactMed®). 2006;Bethesda (MD): National Institute of Child Health and Human Development; 2006-. Rhubarb entry dated 15 February 2025..PubMedUsed to support: NIH LactMed entry: Rheum officinale and Rheum palmatum root contains cathartic anthraquinones and astringent tannins; most uses are not supported by well-controlled trials; other rhubarb species are used mainly as foods, and Chinese and garden rhubarb are generally recognized as safe as foods by FDA. Two very old studies found no effect on breastfed infants, but most recent reviewers advise against use while breastfeeding.
  14. Albersmeyer M, Hilge R, Schröttle A, Weiss M, Sitter T, Vielhauer V. Acute kidney injury after ingestion of rhubarb: secondary oxalate nephropathy in a patient with type 1 diabetes. BMC Nephrol. 2012;13:141. doi: 10.1186/1471-2369-13-141.PubMedUsed to support: Case report (full text read) of acute kidney failure with oxalate crystal deposits in the kidney and raised blood oxalate after heavy dietary intake of rhubarb by an adult with type 1 diabetes and mild diabetic kidney changes. The authors note the high oxalate content of rhubarb as a food. Concerns culinary rhubarb, not root supplements; a single case.
  15. Zhang L, Chen J, Jiang D, Zhang P. Adjuvant treatment with crude rhubarb for patients with systemic inflammation reaction syndrome/sepsis: a meta-analysis of randomized controlled trials. J Crit Care. 2015;30(2):282-9. doi: 10.1016/j.jcrc.2014.11.008.PubMedUsed to support: Meta-analysis of 15 randomized trials (869 patients) of crude rhubarb added to usual care in systemic inflammation or sepsis. Inflammatory markers, illness severity scores and gastrointestinal dysfunction (risk ratio 0.28) were lower with rhubarb, but 28-day mortality was not significantly reduced (risk ratio 0.60, 95% CI 0.36 to 1.00).
  16. Yuen MF, Tam S, Fung J, Wong DK, Wong BC, Lai CL. Traditional Chinese medicine causing hepatotoxicity in patients with chronic hepatitis B infection: a 1-year prospective study. Aliment Pharmacol Ther. 2006;24(8):1179-86. doi: 10.1111/j.1365-2036.2006.03111.x.PubMedUsed to support: Prospective Hong Kong study of 45 hospitalized hepatitis B patients with liver dysfunction; in 7 it was attributed to traditional Chinese medicine. Rheum palmatum was among the herbs identified as possibly liver-toxic, but, as the EU assessment notes, it was taken with more than ten other herbs, so causality could not be established.